Skip to Content

PD353 400 (Rezulin 400 mg)

Generic Name: troglitazone

Pill with imprint PD353 400 is Pink, Elliptical / Oval and has been identified as Rezulin 400 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Rezulin is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. There is no proven risk in humans during pregnancy. Rezulin 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for PD353 400

Rezulin

Generic Name:
troglitazone
Imprint:
PD353 400
Strength:
400 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00071-0353

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide